☰

Jihyun Park - Publications

Affiliations: 
2009-2015 Medicinal Chemistry University of Texas at Austin, Austin, Texas, U.S.A. 
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Bertucci F, et al. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 4: 236. PMID 38282551 DOI: 10.1158/2767-9764.CRC-24-0046  0.629
2023 Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Shen Y, et al. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 3: 1078-1092. PMID 37377604 DOI: 10.1158/2767-9764.CRC-22-0330  0.752
2023 Park J, Koh D, Lee YH, Lim Y, Shin SY. Effect of hybrid compounds of stilbene and pentadienone on inhibition of tubulin polymerization. Anti-Cancer Agents in Medicinal Chemistry. PMID 36797615 DOI: 10.2174/1871520623666230216091116  0.335
2022 Park E, Lee C, Park J, Liu J, Hong J, Shin DY, Byun JM, Yun H, Koh Y, Yoon SS. Mitigating the BFL1-mediated antiapoptotic pathway in diffuse large B cell lymphoma by inhibiting HDACs. Leukemia & Lymphoma. 1-12. PMID 36331521 DOI: 10.1080/10428194.2022.2140282  0.326
2022 Lee HS, Kim DH, Lee IS, Park JH, Martin G, Safe S, Kim KJ, Kim JH, Jang BI, Lee SO. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo. International Journal of Molecular Sciences. 23. PMID 35563670 DOI: 10.3390/ijms23095280  0.394
2022 Shin SY, Jung E, Yeo H, Ahn S, Lee Y, Park J, Kang H, Yeo WS, Koh D, Lim Y. Design, synthesis, and biological activities of 3-((4,6-diphenylpyrimidin-2-ylamino)methylene)-2,3-dihydrochromen-4-ones. Bioorganic Chemistry. 120: 105634. PMID 35114524 DOI: 10.1016/j.bioorg.2022.105634  0.374
2021 Park J, Park H, Byun JM, Hong J, Shin DY, Koh Y, Yoon SS. Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with mutations. Oncology Letters. 22: 745. PMID 34539849 DOI: 10.3892/ol.2021.13006  0.311
2021 Park J, Tacam MJ, Chauhan G, Cohen EN, Gagliardi M, Iles LR, Ueno NT, Battula VL, Sohn YK, Wang X, Kim HS, Krishnamurthy S, Fowlkes NW, Green MM, Bartholomeusz GA, et al. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression. Breast Cancer Research and Treatment. PMID 34241740 DOI: 10.1007/s10549-021-06316-2  0.442
2020 Park J, Jang KM, Park KK. Apamin Suppresses LPS-Induced Neuroinflammatory Responses by Regulating SK Channels and TLR4-Mediated Signaling Pathways. International Journal of Molecular Sciences. 21. PMID 32560481 DOI: 10.3390/ijms21124319  0.337
2020 Gagliardi M, Pitner MK, Park J, Xie X, Saso H, Larson RA, Sammons RM, Chen H, Wei C, Masuda H, Chauhan G, Kondo K, Tripathy D, Ueno NT, Dalby KN, et al. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific Reports. 10: 8537. PMID 32444778 DOI: 10.1038/S41598-020-65250-3  0.818
2020 Shin SY, Park J, Jung Y, Lee YH, Koh D, Yoon Y, Lim Y. Anticancer activities of cyclohexenone derivatives Applied Biological Chemistry. 63. DOI: 10.1186/s13765-020-00567-1  0.342
2020 Yoo H, Kim JK, Choi JY, Song SK, Park J, Jeon A, Lee JH, Chang SK, Song Y. 218 A preclinical study of IMC-002, a fully human therapeutic antibody safely targeting CD47 in cancer Journal For Immunotherapy of Cancer. 8: A237-A237. DOI: 10.1136/jitc-2020-sitc2020.0218  0.302
2019 Kaoud TS, Johnson WH, Ebelt ND, Piserchio A, Zamora-Olivares D, Van Ravenstein SX, Pridgen JR, Edupuganti R, Sammons R, Cano M, Warthaka M, Harger M, Tavares CDJ, Park J, Radwan MF, et al. Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo. Nature Communications. 10: 5232. PMID 31745079 DOI: 10.1038/S41467-019-12996-8  0.691
2019 Park H, Kim D, Kim D, Park J, Koh Y, Yoon SS. Truncation of MYH8 tail in AML: a Novel prognostic marker with increase cell migration and epithelial-mesenchymal transition utilizing RAF/MAPK pathway. Carcinogenesis. PMID 31430364 DOI: 10.1093/carcin/bgz146  0.373
2018 Shin SY, Lee J, Park J, Lee Y, Ahn S, Lee JH, Koh D, Lee YH, Lim Y. Design, synthesis, and biological activities of 1-aryl-(3-(2-styryl)phenyl)prop-2-en-1-ones. Bioorganic Chemistry. 83: 438-449. PMID 30448722 DOI: 10.1016/J.Bioorg.2018.11.005  0.347
2017 Cho HJ, Park JH, Nam JH, Chang YC, Park B, Hoe HS. Ascochlorin suppresses MMP-2-mediated migration and invasion by targeting FAK and JAK-STAT signaling cascades. Journal of Cellular Biochemistry. PMID 28569433 DOI: 10.1002/jcb.26179  0.427
2017 Park JH, Park B, Park KK. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways. Toxins. 9. PMID 28406452 DOI: 10.3390/toxins9040138  0.338
2017 Park J, Cohen EN, Chauhan G, Lee J, Ueno NT, Tripathy D, Reuben JM, Bartholomeusz C. Abstract 897: PEA-15 regulates epithelial-mesenchymal transition and invasive behavior through its phosphorylation in triple-negative breast cancer Cancer Research. 77: 897-897. DOI: 10.1158/1538-7445.Am2017-897  0.449
2016 Park JH, Yoon J, Park B. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 23: 1716-1726. PMID 27912873 DOI: 10.1016/j.phymed.2016.10.010  0.398
2016 Park JH, Cho YY, Yoon SW, Park B. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells. International Journal of Oncology. PMID 27573547 DOI: 10.3892/ijo.2016.3585  0.481
2016 Noh KW, Park J, Joo EH, Lee EK, Choi EY, Kang MS. ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation. Oncotarget. PMID 27009860 DOI: 10.18632/oncotarget.8177  0.361
2016 Kaoud TS, Xie X, Park J, Tavares CDJ, Mitra S, Cano M, Radwan MF, Bartholomeusz C, Dalby KN. Abstract A17: TRPM7 kinase domain is involved in breast tumor cell metastasis Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A17  0.838
2016 Ebelt ND, Taveres CDJ, Xie X, Naguib YW, Jose J, Ruwona TB, Devkota AK, Park J, Kaoud TS, Anslyn EV, Chang JT, Cui Z, Bartholomeusz C, Dalby KN. Abstract 3774: KD06 is a novel anti-cancer drug that causes cell death in triple-negative breast cancer cell lines and tumor xenografts Cancer Research. 76: 3774-3774. DOI: 10.1158/1538-7445.Am2016-3774  0.82
2015 Kaoud TS, Xie X, Park J, Tavares CDJ, Mitra S, Cano M, Sammons RM, Radwan MF, Bartholomeusz C, Dalby KN. Abstract 3569: Inhibition of the TRPM7 kinase domain inhibits breast cancer cell migration and invasion and tumor metastasis Cancer Research. 75: 3569-3569. DOI: 10.1158/1538-7445.Am2015-3569  0.797
2014 Wang Q, Park J, Devkota AK, Cho EJ, Dalby KN, Ren P. Identification and validation of novel PERK inhibitors. Journal of Chemical Information and Modeling. 54: 1467-75. PMID 24745945 DOI: 10.1021/Ci500114R  0.771
2014 Tavares CDJ, Jose J, Devkota AK, Park J, Kaoud TS, Anslyn EV, Dalby KN. Abstract 5462: Antiproliferative and cytotoxic activities of 5-(nonyloxy)tryptamine derivatives in breast cancer cells Cancer Research. 74: 5462-5462. DOI: 10.1158/1538-7445.Am2014-5462  0.788
2014 Park J, Wang Q, Kaoud TS, Tavares CDJ, Edupuganti R, Ren P, Dalby KN. Abstract 513: Investigating stress-response pathways in pancreatic cancer cells using novel PERK inhibitors Cancer Research. 74: 513-513. DOI: 10.1158/1538-7445.Am2014-513  0.812
2013 Kaoud TS, Park J, Mitra S, Tavares CDJ, Tseng A, Dalby KN. Abstract 4551: Identification of TRPM7 kinase inhibitors. Cancer Research. 73: 4551-4551. DOI: 10.1158/1538-7445.Am2013-4551  0.836
2013 Park J, Wang Q, Ren P, Dalby KN. Abstract 4542: Towards the identification of PKR-like endoplasmic reticulum kinase (PERK) inhibitors. Cancer Research. 73: 4542-4542. DOI: 10.1158/1538-7445.Am2013-4542  0.77
2012 Kaoud TS, Yan C, Mitra S, Tseng CC, Jose J, Taliaferro JM, Tuohetahuntila M, Devkota A, Sammons R, Park J, Park H, Shi Y, Hong J, Ren P, Dalby KN. From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules. Acs Medicinal Chemistry Letters. 3: 721-725. PMID 23002419 DOI: 10.1021/Ml300129B  0.74
2003 Chang TS, Kim MJ, Ryoo K, Park J, Eom SJ, Shim J, Nakayama KI, Nakayama K, Tomita M, Takahashi K, Lee MJ, Choi EJ. p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. The Journal of Biological Chemistry. 278: 48092-8. PMID 12963725 DOI: 10.1074/Jbc.M309421200  0.434
2002 Park HS, Kim MS, Huh SH, Park J, Chung J, Kang SS, Choi EJ. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. The Journal of Biological Chemistry. 277: 2573-8. PMID 11707464 DOI: 10.1074/jbc.M110299200  0.441
2001 Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, et al. Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1 Journal of Biological Chemistry. 276: 12749-12755. PMID 11278289 DOI: 10.1074/Jbc.M005561200  0.403
1996 Shim J, Lee H, Park J, Kim H, Choi E. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381: 804-807. PMID 8657286 DOI: 10.1038/381804A0  0.346
Show low-probability matches.